TriSalus Life Sciences (TLSI) Short Interest Ratio & Short Volume

Short interest is the volume of TriSalus Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 276,300 shares of TLSI short. 11.71% of TriSalus Life Sciences' shares are currently sold short. Learn More on TriSalus Life Sciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TLSI shares currently have a short interest ratio of 9.0. Learn More on TriSalus Life Sciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.71% of TriSalus Life Sciences' floating shares are currently sold short.

TriSalus Life Sciences saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 276,300 shares, a decrease of 3.9% from the previous total of 287,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

TriSalus Life Sciences currently has issued a total of 26,760,000 shares. Some of TriSalus Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TriSalus Life Sciences currently has a public float of 2,360,000 shares.

11.71% of TriSalus Life Sciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TriSalus Life Sciences: Xeris Biopharma Holdings, Inc. (6.03%), GeneDx Holdings Corp. (6.60%), Foghorn Therapeutics Inc. (6.31%), AVITA Medical, Inc. (4.97%), 2seventy bio, Inc. (13.60%), Sight Sciences, Inc. (4.75%), Nanobiotix S.A. (0.11%), Sutro Biopharma, Inc. (3.49%), Puma Biotechnology, Inc. (9.60%), AngioDynamics, Inc. (5.44%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling TLSI is an investing strategy that aims to generate trading profit from TriSalus Life Sciences as its price is falling. TLSI shares are trading down $0.58 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for TriSalus Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TLSI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLSI, twice per month. The most recent reporting period available is April, 15 2024.